Interestingly, even in TβRIIiΔEC mice transplanted with LLC-GFP, decreased expression of CD44 was observed in pulmonary vascular ECs one month after tamoxifen administration (Figure S6), suggesting that TGF-β signaling regulates CD44 expression independently of the presence of cancer cells. The gene discussed is TGFB1; the disease is cancer.